Compare BRZE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRZE | SRPT |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2021 | 2000 |
| Metric | BRZE | SRPT |
|---|---|---|
| Price | $18.64 | $16.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 24 | 28 |
| Target Price | ★ $43.58 | $25.56 |
| AVG Volume (30 Days) | ★ 2.6M | 2.0M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.73 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $593,410,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $25.69 | N/A |
| Revenue Next Year | $17.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.78 | 15.58 |
| 52 Week Low | $15.26 | $10.42 |
| 52 Week High | $43.89 | $103.32 |
| Indicator | BRZE | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 39.99 |
| Support Level | $15.76 | $15.51 |
| Resistance Level | $21.05 | $19.55 |
| Average True Range (ATR) | 1.13 | 0.87 |
| MACD | 0.35 | 0.12 |
| Stochastic Oscillator | 56.07 | 29.93 |
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.